Tandem Diabetes Care Inc (TNDM)

Operating profit margin

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Operating income (ttm) US$ in thousands -233,230 -215,947 -231,895 -205,326 -92,847 -62,332 -7,119 10,552 22,653 28,577 19,848 2,379 -7,957 -24,475 -29,470 -19,298 -16,722 -18,306 -28,011 -40,143
Revenue (ttm) US$ in thousands 739,136 762,842 785,031 789,444 796,589 786,083 761,228 733,133 697,845 655,914 596,546 531,931 490,754 431,087 406,936 394,167 362,230 330,031 274,984 212,752
Operating profit margin -31.55% -28.31% -29.54% -26.01% -11.66% -7.93% -0.94% 1.44% 3.25% 4.36% 3.33% 0.45% -1.62% -5.68% -7.24% -4.90% -4.62% -5.55% -10.19% -18.87%

December 31, 2023 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $-233,230K ÷ $739,136K
= -31.55%

The operating profit margin of Tandem Diabetes Care Inc has shown a declining trend over the past eight quarters, with negative values indicating that the company's operating expenses exceed its operating income. The margin deteriorated from -7.71% in Q4 2022 to -20.66% in Q4 2023, reflecting a significant decrease in profitability.

This downward trend suggests that the company may be facing challenges in efficiently managing its operating expenses or generating sufficient revenue to cover these costs. Investors and stakeholders should closely monitor this metric to assess the company's ability to improve operational efficiency and enhance profitability in the future.


Peer comparison

Dec 31, 2023